TriApex Laboratories Co., Ltd.

TriApex is an innovative China-based contract research organization providing integrated solutions for nonclinical and clinical R&D in specialized disease areas such as ophthalmology, CNS disorders, metabolic disease, and cardiovascular conditions. The company is accredited by CFDA for GLP studies and AAALAC for animal welfare standards. It has supported regulatory submissions to both Chinese (CFDA/NMPA) and US FDA authorities. With over 1,000 employees globally—including operations in China and the US—TriApex offers expertise in disease models using non-human primates, pharmacodynamics/pharmacokinetics studies, translational medicine/biomarkers work, pathology evaluation, safety assessment of drugs/devices/biologics/cell therapies/iPSCs/organoids evaluation departments. The company has collaborated with top global pharma companies such as AstraZeneca and Merck.